RhumbLine Advisers
CDLX icon

RhumbLine Advisers’s Cardlytics CDLX Stock Holding History

RhumbLine Advisers’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,558
Closed -$101K – 4161
2025
Q1 		$101K Buy
5,558
+239
+4% +$6.83K ﹤0.01% 3385
2024
Q4 		$197K Buy
5,319
+132
+3% +$5.05K ﹤0.01% 3206
2024
Q3 		$166K Sell
5,187
-405
-7% -$22.5K ﹤0.01% 3327
2024
Q2 		$459K Sell
5,592
-93
-2% -$10.1K ﹤0.01% 2746
2024
Q1 		$824K Buy
5,685
+205
+4% +$17.3K ﹤0.01% 2362
2023
Q4 		$505K Buy
5,480
+201
+4% +$20.4K ﹤0.01% 2656
2023
Q3 		$871K Buy
5,279
+307
+6% +$39.9K ﹤0.01% 2290
2023
Q2 		$314K Sell
4,972
-59
-1% -$3.57K ﹤0.01% 2981
2023
Q1 		$171K Sell
5,031
-32
-0.6% -$1.67K ﹤0.01% 2771
2022
Q4 		$293K Buy
5,063
+17
+0.3% +$1.05K ﹤0.01% 2684
2022
Q3 		$474K Buy
5,046
+179
+4% +$25.5K ﹤0.01% 2519
2022
Q2 		$1.09M Buy
4,867
+1,452
+43% +$486K ﹤0.01% 2096
2022
Q1 		$1.88M Buy
3,415
+86
+3% +$52K ﹤0.01% 1846
2021
Q4 		$2.2M Sell
3,329
-87
-3% -$66.5K ﹤0.01% 1825
2021
Q3 		$2.87M Buy
3,416
+9
+0.3% +$9.13K ﹤0.01% 1687
2021
Q2 		$4.33M Buy
3,407
+158
+5% +$178K 0.01% 1499
2021
Q1 		$3.56M Sell
3,249
-68
-2% -$89.8K ﹤0.01% 1597
2020
Q4 		$4.74M Buy
3,317
+223
+7% +$238K 0.01% 1386
2020
Q3 		$2.18M Sell
3,094
-846
-21% -$615K ﹤0.01% 1629
2020
Q2 		$2.76M Buy
3,940
+2,004
+104% +$1.16M ﹤0.01% 1548
2020
Q1 		$677K Buy
1,936
+219
+13% +$155K ﹤0.01% 2041
2019
Q4 		$1.08M Buy
1,717
+281
+20% +$137K ﹤0.01% 2039
2019
Q3 		$481K Buy
1,436
+118
+9% +$37.8K ﹤0.01% 2340
2019
Q2 		$342K Buy
+1,318
New +$264K ﹤0.01% 2549

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $619M AUM 27.68% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

RhumbLine Advisers's CDLX Position: Q2 2025 in Review

RhumbLine Advisers sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 5,558 shares — an estimated $101K sold.

RhumbLine Advisers first reported a position in CDLX in Q2 2019 and held it in 24 quarters. The position peaked at $4.74M in Q4 2020. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • RhumbLine Advisers reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • RhumbLine Advisers sold 5,558 Cardlytics shares in Q2 2025, an estimated $101K.
  • RhumbLine Advisers first reported a position in Cardlytics in Q2 2019 and held it in 24 quarters.
  • RhumbLine Advisers's Cardlytics position peaked at $4.74M in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on RhumbLine Advisers's 13F filing for Q2 2025, filed 12 Aug 2025.